日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas

Botensilimab(Fc增强型抗细胞毒性淋巴细胞相关蛋白-4抗体)联合Balstilimab(抗PD-1抗体)治疗复发/难治性转移性肉瘤患者

Wilky, Breelyn A; Schwartz, Gary K; Gordon, Michael S; El-Khoueiry, Anthony B; Bullock, Andrea J; Henick, Brian; Agulnik, Mark; Singh, Arun; Mahadevan, Daruka; Stebbing, Justin; Delepine, Chloe; Chand, Dhan; Avagyan, Manushak; Wu, Wei; Johnson, Benny; Grossman, Joseph E; O'Day, Steven; Trent, Jonathan C; Jones, Robin L; Tsimberidou, Apostolia M

Genomic, transcriptomic, and immunogenomic landscape of over 1300 sarcomas of diverse histology subtypes

超过1300种不同组织学亚型肉瘤的基因组学、转录组学和免疫基因组学图谱

Soupir, Alex; Ospina, Oscar E; Hampton, Oliver; Churchman, Michelle; Radmacher, Michael; Hedges, Dale; McKean, David; Agius, Phaedra; Zeeshan, Saman; Seligson, Nathan D; Pollock, Raphael; Liebner, David; Chen, James L; Tinoco, Gabriel; Salhia, Bodour; McCarter, Martin; Wilky, Breelyn A; Miller, Benjamin J; Cavnar, Michael J; Groundland, John S; Schneider, Bryan P; Riedlinger, Gregory; Edge, Stephen B; Moskaluk, Christopher A; Cardona, Kenneth; Naqash, Abdul Rafeh; Gonzalez, Ricardo J; Mullinax, John E; Joyce, David M; Binitie, Odion; Douglas Letson, G; Naghavi, Arash O; Druta, Mihaela; Reed, Damon R; Siegel, Erin M; Teer, Jamie K; Fridley, Brooke L; Brohl, Andrew S

Botensilimab (Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (anti-PD-1 antibody) in patients with treatment-refractory ovarian cancer

在难治性卵巢癌患者中,Botensilimab(Fc增强型抗CTLA-4抗体)联合balstilimab(抗PD-1抗体)治疗方案

Porter, Rebecca; Bockorny, Bruno; Corr, Bradley R; Mahadevan, Daruka; Wilky, Breelyn A; El-Khoueiry, Anthony B; Bullock, Andrea J; Hafez, Navid; Moser, Justin; Martynova, Anastasia; Stebbing, Justin; Joshi, Bishnu; Bourdelais, Sean; Delepine, Chloe; Chand, Dhan; Wu, Wei; Johnson, Benny; Grossman, Joseph E; O'Day, Steven J; Matulonis, Ursula A; Gordon, Michael S

A Single-Arm Phase 2 Trial of Doxorubicin Plus Zalifrelimab (Anti-CTLA-4 Antibody) and Balstilimab (Anti-PD-1 Antibody) in Advanced/Metastatic Soft Tissue Sarcomas

多柔比星联合扎利弗利单抗(抗CTLA-4抗体)和巴斯蒂利单抗(抗PD-1抗体)治疗晚期/转移性软组织肉瘤的单臂II期试验

Wilky, Breelyn A; Julian, Katherine A; Maleddu, Alessandra; Mailhot, Anne C; Cartwright, Chelsey R; Gao, Dexiang; Moreno Tellez, Cristiam; Kemp, Lindsey E; Therrien, Nicholas R; Chaudhry, Sumra S; Rytlewski, Jeffrey D; Brockman, Qierra R; Davila, Eduardo; Elias, Anthony D

Molecular Characterization of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma

非典型纤维黄色瘤和多形性真皮肉瘤的分子特征

Klein, Jason C; Wilky, Breelyn A; Ford, Heide L

Novel PLEC-EML4-ALK Double Fusion Underlying Crizotinib Resistance in a Metastatic Inflammatory Myofibroblastic Tumor: A Case Report

转移性炎性肌纤维母细胞瘤中克唑替尼耐药的新型PLEC-EML4-ALK双融合基因:病例报告

Maleddu, Alessandra; Hinz, Trista K; Black, Margaret A; Aisner, Dara L; Marshall, Carrie B; Elias, Anthony D; Wilky, Breelyn A; Heasley, Lynn E; Davies, Kurtis D

Increased accrual of diverse patient populations in oncology phase I clinical trials at the University of Colorado Cancer Center

科罗拉多大学癌症中心肿瘤学I期临床试验中纳入了更多不同类型的患者群体

Alsafar, Ahmed; Kareem, Sama L; Corr, Bradley R; Lieu, Christopher H; Wilky, Breelyn; Davis, S Lindsey; Camidge, D Ross; Jimeno, Antonio; Messersmith, Wells A; Nicklawsky, Andrew; Pacheco, Daniel; Borrayo, Evelinn A; McDermott, Jessica D; Diamond, Jennifer R

Durable response with mutation-guided ALK inhibition in a patient with metastatic epithelioid inflammatory myofibroblastic sarcoma: A case report

一例转移性上皮样炎性肌纤维母细胞肉瘤患者经突变指导的ALK抑制剂治疗后获得持久疗效:病例报告

Chaudhry, Sumra S; Camidge, D Ross; Clay, Michael R; Wilky, Breelyn A

Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial

Afamitresgene autoleucel 用于晚期滑膜肉瘤和黏液样圆形细胞脂肪肉瘤(SPEARHEAD-1):一项国际性、开放标签的 II 期试验

D'Angelo, Sandra P; Araujo, Dejka M; Abdul Razak, Albiruni R; Agulnik, Mark; Attia, Steven; Blay, Jean-Yves; Carrasco Garcia, Irene; Charlson, John A; Choy, Edwin; Demetri, George D; Druta, Mihaela; Forcade, Edouard; Ganjoo, Kristen N; Glod, John; Keedy, Vicki L; Le Cesne, Axel; Liebner, David A; Moreno, Victor; Pollack, Seth M; Schuetze, Scott M; Schwartz, Gary K; Strauss, Sandra J; Tap, William D; Thistlethwaite, Fiona; Valverde Morales, Claudia Maria; Wagner, Michael J; Wilky, Breelyn A; McAlpine, Cheryl; Hudson, Laura; Navenot, Jean-Marc; Wang, Tianjiao; Bai, Jane; Rafail, Stavros; Wang, Ruoxi; Sun, Amy; Fernandes, Lilliam; Van Winkle, Erin; Elefant, Erica; Lunt, Colin; Norry, Elliot; Williams, Dennis; Biswas, Swethajit; Van Tine, Brian A

Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial

Botensilimab联合balstilimab治疗复发/难治性微卫星稳定型转移性结直肠癌:一项I期试验

Bullock, Andrea J; Schlechter, Benjamin L; Fakih, Marwan G; Tsimberidou, Apostolia M; Grossman, Joseph E; Gordon, Michael S; Wilky, Breelyn A; Pimentel, Agustin; Mahadevan, Daruka; Balmanoukian, Ani S; Sanborn, Rachel E; Schwartz, Gary K; Abou-Alfa, Ghassan K; Segal, Neil H; Bockorny, Bruno; Moser, Justin C; Sharma, Sunil; Patel, Jaymin M; Wu, Wei; Chand, Dhan; Rosenthal, Katherine; Mednick, Gabriel; Delepine, Chloe; Curiel, Tyler J; Stebbing, Justin; Lenz, Heinz-Josef; O'Day, Steven J; El-Khoueiry, Anthony B